EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand

Malcolm Hopwood, Elizabeth M. Scott, David Codyre, David Barton, Andrea Puig, Jarrad King, Gero Joks, Ian B. Hickie

Psychiatry Research Communications · 2024-09 · 4 (3) · 100177

DOI: 10.1016/j.psycom.2024.100177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry Research Communications, 2024-09. Verfasst von Malcolm Hopwood und 7 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hopwood, M., Scott, E. M., Codyre, D., Barton, D., Puig, A., King, J., Joks, G., & Hickie, I. B. (2024). A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand. Psychiatry Research Communications, 4(3), 100177. https://doi.org/10.1016/j.psycom.2024.100177

Vancouver

Hopwood M, Scott EM, Codyre D, Barton D, Puig A, King J, et al. A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand. Psychiatry Research Communications. 2024;4(3):100177. doi:10.1016/j.psycom.2024.100177

BibTeX
@article{Hopwood2024,
  author = {Hopwood, Malcolm and Scott, Elizabeth M. and Codyre, David and Barton, David and Puig, Andrea and King, Jarrad and Joks, Gero and Hickie, Ian B.},
  title = {A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand},
  journal = {Psychiatry Research Communications},
  year = {2024},
  volume = {4},
  number = {3},
  pages = {100177},
  doi = {10.1016/j.psycom.2024.100177}
}
Kostenlos starten →